Biotechblog

Biogen/Idec: still a matter of size

June 30, 2003 Comments Off Posted in: General Biotechnology

Biogen/Idec: still a matter of size The merger of Biogen and Idec Pharmaceuticals, announced June 23, is likely to help the two relatively isolated companies increase presence in their disease areas. The annual R&D budget for the new pharmaceutical entity, to be called Biogen Idec Inc, will be $500 million, according to company reports.

The State of Biotechnology

June 19, 2003 Comments Off Posted in: General Biotechnology

The State of Biotechnology Researchers, government officials and industry executives will gather this weekend in Washington for the Biotechnology Industry Organization’s annual convention. Topics to be addressed at BIO 2003 range from science and regulatory affairs to bioethics and homeland security.